Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM (Nangibotide) in Patients With Septic Shock
Clinical trial NCT03158948 · COMPLETED
Trial details
- NCT number
- NCT03158948
- Sponsor
- Inotrem
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-03
- Primary completion
- 2018-06-13
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.